about
Role of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisMucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J miceInflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.The changing microbial environment and chronic inflammatory disorders.A limited role for regulatory T cells in post-ischemic neovascularizationIL-25 inhibits atherosclerosis development in apolipoprotein E deficient miceIf It's Not One Thing, It's Another: An Inverse Relationship of Malignancy and Atherosclerotic Disease.Peripheral Blood Lymphocyte Subsets (CD4+, CD8+ T Cells, NK Cells) in Patients with Cardiovascular and Neurological Complications after Carotid Endarterectomy.Dendritic Cells Expressing Triggering Receptor Expressed on Myeloid Cells-1 Correlate with Plaque Stability in Symptomatic and Asymptomatic Patients with Carotid Stenosis.Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome.The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability?Autoimmunity in atherosclerosis: a protective response losing control?Regulatory T-cell immunity and its relevance to atherosclerosis.T-cell costimulation and coinhibition in atherosclerosis.2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in AtherosclerosisAntigen-induced immunomodulation in the pathogenesis of atherosclerosis.Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis.Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?The Role of Immunogenicity in Cardiovascular Disease.Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis.Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaquesAtherosclerosis and the role of immune cells.Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis.The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?Crosstalk between red blood cells and the immune system and its impact on atherosclerosis.CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis.The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice.Tregs and human atherothrombotic diseases: toward a clinical application?Changes in CD4+CD25+ Tregs in the pathogenesis of atherosclerosis in ApoE-/- mice.Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study.Immunological aspects of atherosclerosis: Figure 1Implication de l’immunité innée au-delà de la réponse à l’infection — L’athérosclérose: une maladie inflammatoireT lymphocyte autoreactivity in inflammatory mechanisms regulating atherosclerosisComparison of Oral Tolerance to ApoB and HSP60 Peptides in Preventing Atherosclerosis Lesion Formation inApob48−/Ldlr−MiceCD4+CD56+natural killer T-like cells secreting interferon-γ are associated with incident coronary eventsThe Pivotal Role of Thymus in Atherosclerosis Mediated by Immune and Inflammatory Response
P2860
Q26777991-1C4FAE28-3104-4C9E-AC23-A5184E88CDF9Q27335174-F3BCD08C-B377-4768-8FD6-0A02DED8A510Q33805176-007E058F-DE3D-4C97-A76C-975A303502FCQ33846659-C6661533-9A12-466F-AF75-F5A486E52BA1Q33852551-0B0590FB-C762-4078-BE4C-BC0D39399343Q35023076-0FED81F9-B703-4D3E-A277-B12B64220FA4Q35637017-DA9D8C42-BD64-40F0-95DA-B817FD16C3A8Q35723160-4EA1DF6F-1DD8-4BC0-A2F3-66A889AEFF2FQ36009227-81C47FE2-EEE2-469B-B5A4-CA82470C71A2Q36298357-A3DA4FF2-5DA1-428A-B800-A9C0A391235FQ36470227-F6B2CA4D-8191-4C0E-9A59-8C32BC073F18Q37138017-1933BF43-1152-42FE-A788-AEAB573FA7B1Q37138025-7A049C83-B667-4DFE-BE09-2E894DDD8519Q37143018-C3DCF8C6-E77E-4EA4-A034-9AAACC2605FEQ37146276-0BCB94BA-3F17-45D8-8BED-E55F680CB6F4Q37190468-042ECCBB-A61C-4382-9B90-D898FE223578Q37230396-93237344-0C09-4C98-95FA-017065CE7561Q37361475-5C2761AD-314B-4809-8B50-71ABDC51656DQ37461480-CDEDA523-D956-41F7-87D5-05095F480551Q37560012-76A17233-B887-436F-8796-1EBB2BFC6C84Q37866627-AB404CD5-E46A-473C-AF4B-1D11A224DF3DQ37892623-E7CDD0FC-8EF3-446C-BAF5-180184F2BE5BQ37942858-4952462B-2284-4139-837F-8911A54E0721Q38423257-94C6BEA7-393F-49EC-AEAE-BF3157276850Q38788255-DF3F77ED-3AA3-4183-BA0B-4BEFF34722C4Q40452360-9CC46569-DD4E-4D29-8D8B-A28A120672D0Q41341475-3D21BEB3-4822-4BB6-A17D-4DA0A209962BQ41576199-2E14F363-05CF-43B7-A9D5-19A983A25D3CQ41767127-E2808B87-6B49-4F36-B507-6B02B524777EQ42750316-84C4E378-678F-41A0-B6E5-8422CEE3737FQ43104927-58758A2D-C027-4E6D-ACFA-9CC2077ABD17Q43235071-F0516A09-6AA0-4D6C-8314-586E2599B208Q57132246-EEE50F97-0F63-4FAD-A36F-254D60524F4DQ58148747-F6C5D1A2-5F94-418B-9143-60BFE3D5E735Q58914607-97974D86-AFA9-435B-B2C1-6A57A8384BCBQ58919397-CC9CC01C-D95B-4582-B2D1-8B4985E8EA61Q59114862-0786C343-BC69-4C5C-8740-69B264D47A09Q59133277-9F3FCDA8-A5C3-4232-A137-F147D5379AAF
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Regulatory T-cell immunity in atherosclerosis.
@ast
Regulatory T-cell immunity in atherosclerosis.
@en
type
label
Regulatory T-cell immunity in atherosclerosis.
@ast
Regulatory T-cell immunity in atherosclerosis.
@en
prefLabel
Regulatory T-cell immunity in atherosclerosis.
@ast
Regulatory T-cell immunity in atherosclerosis.
@en
P1476
Regulatory T-cell immunity in atherosclerosis.
@en
P2093
Hafid Ait-Oufella
P304
P356
10.1016/J.TCM.2007.03.001
P577
2007-05-01T00:00:00Z